RankAlpha logo
Back to Rankings

USNA

USANA Health SciencesC
NYSE / Household & Personal Products
Last Price
Quote time unavailable
View Chart

AI scenario view

RankAlpha Sentiment Codex
B+
Bull case
20%
Probability
Target price
$20.00
Analysis reference price unavailable
Analysis 2026-08-07 · RankAlpha Sentiment Codex
Most likely
B
Base case
50%
Probability
Target price
$15.00
Analysis reference price unavailable
Analysis 2026-08-07 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$10.00
Analysis reference price unavailable
Analysis 2026-08-07 · RankAlpha Sentiment Codex

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2026-08-07
Recent news sentiment (30D)
+35.0
Positive
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
-
Unavailable
Sentiment proxy
+59.3
Score

AI commentary

Post-earnings news tone is mixed-negative: the company reiterated its long-term transformation thesis, but the Q2 release disclosed weaker venture performance and a major guidance reduction. The latest packet anchor is $14.89 on August 6; a verified post-print percentage reaction, analyst revisions, and social coverage are unavailable. Low coverage and loose peers warrant monitoring rather than a high-conviction directional call.

RankAlpha Sentiment Codex - 2026-08-07
Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact
standard
Confidence
-

AI events

2026-08-14catalystQ2 earnings and guidance resetHigh impact

Q2 net sales fell 5% year over year to $223 million, adjusted EPS was negative $0.07, and fiscal 2026 guidance was reduced materially, including updated consolidated sales of $910 million and adjusted EPS of $0.76 [#SEC-8K-2026-08-04]. Near-term sentiment and estimates may remain pressured.

2026-11-05eventCore Nutritional stabilizationHigh impact

Core Nutritional results were described as generally in line with expectations; Greater China sales increased 1% year over year, but core active customers declined 8% and Greater China active customers declined 6% [#SEC-8K-2026-08-04]. The next operating update must show customer and revenue stabilization.

2026-12-31catalystOmnichannel execution and venture recoveryHigh impact

Management continues to invest in product innovation, Brand Partner incentives, channel expansion, and technology modernization. Hiya and Rise remain potential long-term growth engines, but Hiya revenue and subscribers fell 17% year over year and Rise experienced a packaging disruption [#SEC-8K-2026-08-04].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo
As of 2026-08-07 • Updated nightlySource: Internal modelMethodology